Examination of disinfection method for urine after BCG intravesical infusion therapy

Examination of disinfection method for urine after BCG intravesical infusion therapy - Examination of disinfection method for urine after BCG intravesical infusion therapy

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000046337

Enrollment

Registered

2022-01-01

Start date

2021-12-15

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Bladder cancer

Interventions

Disinfect BCG-containing urine with Etaprocol, and examine whether it is more effective and safer than disinfection with sodium hypochlorite. Disinfect BCG-containing urine with Etaprocol, and examine

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients diagnosed with non-muscle invasive bladder cancer and required BCG intravesical instillation therapy

Exclusion criteria

Exclusion criteria: Patients who are contraindicated for BCG intravesical instillation therapy

Design outcomes

Primary

Measure	Time frame
Evaluation of the temperature rise that occurs when each disinfectant solution is added to BCG-containing urine and mixed together	—

Secondary

Measure	Time frame
Evaluation of the concentration of gas generated when each disinfectant solution is added and mixed with BCG-containing urine, the disinfecting effect of each disinfectant on Mycobacterium tuberculosis, and the sensory degree of the odor generated at that time.	—

Countries

Japan

Contacts

Public ContactTomohiro Kameda

Haga red cross hospital Urology

kamedadesu1002@yahoo.co.jp0285-82-2195

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026